Tong Ren Tang Technologies Co. Ltd. (HKG: 1666)

Market Cap	6.66B
Revenue (ttm)	7.39B
Net Income (ttm)	699.27M
Shares Out	1.28B
EPS (ttm)	0.55
PE Ratio	9.52
Forward PE	9.49
Dividend	0.19 (3.70%)
Ex-Dividend Date	Jun 14, 2024

Volume	591,000
Open	5.15
Previous Close	5.15
Day's Range	5.15 - 5.29
52-Week Range	4.63 - 7.03
Beta	1.04
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2024

About Tong Ren Tang Technologies

Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and internationally. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services. In addition, it is involved in the wholesale and retail sale of Chinese medicines and healthcare products; technological development ...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1669
• Employees: 4,101
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1666

Financial Performance

In 2023, Tong Ren Tang Technologies's revenue was 6.77 billion, an increase of 13.04% compared to the previous year's 5.99 billion. Earnings were 590.19 million, an increase of 1.25%.

Financial numbers in CNY